DE60032339D1 - Integriertes assay für organfunktion, drogen und/oder metaboliten - Google Patents

Integriertes assay für organfunktion, drogen und/oder metaboliten

Info

Publication number
DE60032339D1
DE60032339D1 DE60032339T DE60032339T DE60032339D1 DE 60032339 D1 DE60032339 D1 DE 60032339D1 DE 60032339 T DE60032339 T DE 60032339T DE 60032339 T DE60032339 T DE 60032339T DE 60032339 D1 DE60032339 D1 DE 60032339D1
Authority
DE
Germany
Prior art keywords
metabolites
drugs
organ function
integrated assay
organ
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032339T
Other languages
English (en)
Other versions
DE60032339T2 (de
Inventor
F Burd
V Edelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LifeScan Inc filed Critical LifeScan Inc
Application granted granted Critical
Publication of DE60032339D1 publication Critical patent/DE60032339D1/de
Publication of DE60032339T2 publication Critical patent/DE60032339T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/52Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
DE60032339T 1999-03-08 2000-03-01 Integriertes assay für organfunktion, drogen und/oder metaboliten Expired - Lifetime DE60032339T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US264249 1981-05-15
US26424999A 1999-03-08 1999-03-08
PCT/US2000/005369 WO2000054051A1 (en) 1999-03-08 2000-03-01 Integrated assay for organ function, drugs and/or metabolites

Publications (2)

Publication Number Publication Date
DE60032339D1 true DE60032339D1 (de) 2007-01-25
DE60032339T2 DE60032339T2 (de) 2007-04-12

Family

ID=23005201

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032339T Expired - Lifetime DE60032339T2 (de) 1999-03-08 2000-03-01 Integriertes assay für organfunktion, drogen und/oder metaboliten

Country Status (8)

Country Link
US (1) US6627153B1 (de)
EP (1) EP1159612B1 (de)
AT (1) ATE348334T1 (de)
AU (1) AU3862400A (de)
DE (1) DE60032339T2 (de)
DK (1) DK1159612T3 (de)
HK (1) HK1042942B (de)
WO (1) WO2000054051A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7585680B2 (en) * 2003-08-28 2009-09-08 Marshfield Medical Research And Education Foundation Method and device for monitoring medication usage
US20080274552A1 (en) * 2007-05-04 2008-11-06 Brian Guthrie Dynamic Information Transfer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6279362A (ja) * 1985-10-02 1987-04-11 Fuji Photo Film Co Ltd 酵素活性測定に用いる分析要素
US4752568A (en) * 1986-01-13 1988-06-21 Eastman Kodak Company Labeled hydantoin conjugate and its use in analytical element and immunoassays
CA2010165A1 (en) * 1989-03-13 1990-09-13 Richard L. Hurtle Compact semi-programmable device for reading reagent test strips and method relating thereto
US5232668A (en) * 1991-02-27 1993-08-03 Boehringer Mannheim Corporation Test strip holding and reading mechanism for a meter
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
US6306347B1 (en) * 1998-01-21 2001-10-23 Bayer Corporation Optical sensor and method of operation

Also Published As

Publication number Publication date
HK1042942A1 (en) 2002-08-30
DK1159612T3 (da) 2007-01-22
DE60032339T2 (de) 2007-04-12
WO2000054051A1 (en) 2000-09-14
EP1159612B1 (de) 2006-12-13
US6627153B1 (en) 2003-09-30
HK1042942B (zh) 2007-09-14
ATE348334T1 (de) 2007-01-15
AU3862400A (en) 2000-09-28
EP1159612A1 (de) 2001-12-05

Similar Documents

Publication Publication Date Title
SV2006002100A (es) Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos ref. p-sv-78.159/msu
DE60122723D1 (de) Vorrichting zur transdermalen abnahme und verabreichung von einer substanz beim patient
DE60130373D1 (de) Messstreifenspenderanordnung
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
ATE337817T1 (de) Medizinisches gerät
BR0111298A (pt) Moduladores seletivos dos receptores de andrógenos e métodos para identificação, projeto e uso dos mesmos
ATE548074T1 (de) Programmierapparat mit interner antenne und display für eine medizinische vorrichtung
CL2008002866A1 (es) Uso de (s,s)-reboxetina en la preparacion de un medicamento util en el tratamiento de un trastorno adictivo, trastorno mental, trastorno de deficit atencional, trastorno bipolar, obesidad, trastorno de panico, trastorno psicotico, sindrome de inhibicion selectiva de la recaptacion de serotonina, entre otras (sol. div. 1765-00).
ATE535212T1 (de) Implantierbare vorrichtung zur arzneimittelabgabe und für verbesserte sichtbarkeit
BRPI0508894A (pt) meios para administração transdérmica de nicotina e uso
DE60038895D1 (de) Messgerät mit integrierter datenbank und vereinfachter telemedizinfähigkeit
CR20120119A (es) Moduladores del receptor glucocorticoide
ES2128411T3 (es) Inhalador de polvo con soportes de polvo con microestructuras regulares.
EA200700681A1 (ru) Активирующие агенты для металлоценовых компонентов на основе гафния
ATE417560T1 (de) Chirurgischer nagel
DE60032339D1 (de) Integriertes assay für organfunktion, drogen und/oder metaboliten
NO20050216L (no) Steroidkonjugater samt fremstilling og anvendelse derav
CY1107062T1 (el) ΧΡΗΣΗ ΔΡΑΣΤΙΚΩΝ ΟΥΣΙΩΝ ΜΕ ΔΡΑΣΗ ΑΓΩΝΙΣΤΗ μ-ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΚΑΙ ΔΡΑΣΗ ΑΝΤΑΓΩΝΙΣΤΗ ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΜΕΣΑ ΣΥΝΔΥΑΣΜΟΥ ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΚΑΡΚΙΝΟΥ
DE69731649D1 (de) Konjugate und spezifische immuntests des methadonmetaboliten 2-ethylidin-1,5-dimethyl-3,3-diphenyl-3,3-diphenylpyrrolidin
BR0309684A (pt) O tratamento de dor com ifendropil
DE602007010268D1 (de) Diagnostikum und therapeutikum gegen bauchspeicheldrüsenkrebs
DE59913117D1 (de) Blindungsvorrichtung für klinische prüfungen
DE602004019818D1 (de) Pharmazeutische zusammensetzungen mit platin-komplexen mit sekundären xanthaten und ihre therapeutischen anwendungen
WO2007065110A3 (en) Medical instrument holder
BR0213014A (pt) Sistema para teste de diagnóstico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition